|
![]() |
||
Citation Report per Year (Source: ISI Web of KnowledgeSM / Web of Science®) |
2010
Orlandi A, Chavakis E, Seeger F, Tjwa M, Zeiher A, Dimmeler S. Long-term diabetes impairs repopulation of hematopoietic progenitor cels and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol 2010; to be published
Moura R, Fadini GP, Tjwa M. Induced pluripotent stem (iPS) cells and endothelial cell generation: SIRT-ainly a good idea! Atherosclerosis 2010; doi: 10.1016/j.atherosclerosis.2010.06.031
Seijkens T, Engel D, Tjwa M, Lutgens E. The role of CD154 in hematopoietic development. Thromb Hemost 2010; to be published
Fadini GP, Tjwa M. A role for TGF-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells. Atherosclerosis 2010;211(1):32-5
Loges S*, Schmidt T*, Tjwa M, Van Geyte K, Lievens D, Lutgens E, Vanhoutte D, Borgel D, Plaisance S, Hoylaerts M, Luttun A, Dewerchin M, Jonckx B, Carmeliet P (*equally contributed). Malignant cells fuel tumor growth by educating infiltrated leukocytes to produce the mitogen Gas6. Blood 2010;115:2264-73 ("recommended (3.0)" in Faculty of 1000)
Maes C, Goossens S, Bartunkova S, Drogat B, Coenegrachts L, Stockmans I, Moermans K, Nyabi O, Haigh K, Naessens M, Haenebalcke L, Tuckermann J, Tjwa M, Carmeliet P, Mandic V, David J, Behrens A, Nagy A, Carmeliet G, Haigh J. Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones. EMBO J 2010;29(2):424-41
2009
Tjwa M, Moura R, Moons L, Plaisance S, De Mol M, Jansen S, Dewerchin M, Verfaillie C, Carmeliet P. Fibrinolysis-independent role of plasmin and its activators in the hematopoietic recovery after myeloablation. J Cell Mol Med 2009;13:4587-95
Tjwa M, Moons L, Lutgens E. Pleiotropic role of growth arrest-specific gene 6 in atherosclerosis. Curr Opin Lipidol. 2009;20(5):386-92
Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher A, Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009;324:1710-3 ("exceptional (9.6)" in Faculty of 1000)
Tintu A, Rouwet E, Verlohren S, Brinkmann J, Ahmad S, Crispi F, Van Bilsen M, Carmeliet P, Staff AC, Tjwa M, Cetin I, Gratacos E, Hernandez-Andrade E, Hofstra L, Jacobs M, Lamers WH, Morano I, Safak E, Ahmed A, Le Noble F. Hypoxia Induces Dilated Cardiomyopathy in the Chick Embryo; Mechanism, Intervention, and Long-term Consequences. PLoS ONE 2009;4(4):e5155
Tjwa M, Sidenius N, Moura R, Jansen S, Theunissen K, Andolfo A, De Mol M, Dewerchin M, Moons L, Blasi F, Verfaillie C, Carmeliet P. Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment and mobilization of mouse hematopoietic stem/progenitor cells. J Clin Invest 2009;119(4);1008-18 (highlighted in SciBX 2(11); doi:10.1038/scibx.2009.440)
Tjwa M, Moons L, Verfaillie C, Carmeliet P. Antibiotics may impair hematopoietic recovery after cytotoxic myeloablation. Blood 2009;113:1608-9
Feng Y, Van Eck M, Van Craeyveld E, Jacobs F, Carlier V, Van Linthout S, Erdel M, Tjwa M, De Geest B. Critical role of scavenger receptor-BI expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood 2009;113(3):755-64
2008
Dimmeler S, Tjwa M. Better regenerative output after cellular input: healing hearts by combining bFGF and cell-based therapy. J Am Coll Cardiol 2008;52:1866-8 (also in Highlights of 2008)
Moura R, Tjwa M, Vandervoort P, Vankerckhoven S, Holvoet P, Hoylaerts M. Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE deficient mice. Circ Res 2008;103:1181-89 (with editorial)
Tjwa M, Janssens S, Carmeliet P. Plasmin therapy enhances mobilization of HPCs after G-CSF. Blood 2008;112:4048-50
Poesen K, Lambrechts D, Van Damme P, Dhondt J, Bender F, Frank N, Bogaert E, Claes B, Heylen L, Verheyen A, Raes K, Tjwa M, Eriksson U, Shibuya M, Nuydens R, Van den Bosch L, Meert T, D’Hooghe R, Sendtner M, Robberecht W, Carmeliet P. Novel role for VEGF-receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neuroscience 2008;28:10451-9
Tjwa M, Dimmeler S. A nucleolar weapon in our fight for regenerating adult hearts: nucleostemin and cardiac stem cells. Circ Res 2008;103:4-6
Li X*, Tjwa M*, Van Hove I, Enholm B, Neven E, Paavonen K, Jeltsch M, Diez-Juan T, Sievers R, Chorianopoulos E, Wada H, Vanwildermeersch M, Noel A, Foidart J, Springer M, Von Degenfeld G, Dewerchin M, Blau H, Alitalo K, Eriksson U, Carmeliet P, Moons L (*contributed equally). Re-evaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arterioscler Thromb Vasc Biol 2008;28:1614-1620 (with editorial)
Lutgens E*, Tjwa M*, Garcia de Frutos P, Wijnands E, Beckers L, Dahlback B, Daemen M, Carmeliet P, Moons L (*contributed equally). Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis. J Pathol 2008;216:55-63
Vidal B*, Serrano A*, Tjwa M*, Suelves M, Ardite E, De Mori R, Baeza-Raja B, Martínez de Lagrán M, Lafuste P, Ruiz-Bonilla V, Jardi M, Gherardi R, Christov C, Dierssen M, Carmeliet P, Degen J, Dewerchin M, Muñoz-Cánoves P (*contributed equally). Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta / alternative macrophage activation pathway. Genes Dev 2008;22:1747-52 ("exceptional (9.0)" in Faculty of 1000)
Tjwa M, Bellido L, Lin Y, Lutgens E, Plaisance S, Bono F, Delesque-Touchard N, Herve C, Moura R, Billiau A, Aparicio C, Levi M, Daemen M, Dewerchin M, Lupu F, Arnout J, Herbert J, Waer M, García de Frutos P, Dahlbäck B, Carmeliet P, Hoylaerts M, Moons L. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets and leukocytes. Blood 2008;111:4096-4105 (with editorial)
Angelillo-Scherrer A, Burnier L, Lambrechts D, Fish R, Tjwa M, Plaisance S, Sugamele R, De Mol M, Martinez-Soria E, Flores N, Maxwell P, Lemke G, Goff S, Matsushima G, Earp H, Collen D, Izui S, Schapira M, Conway E, Carmeliet P. Role of Gas6 in erythropoiesis and anemia in mice. J Clin Invest 2008;118(2):583-96
Feng Y, Jacobs F, Van Craeyveld E, Brunaud C, Snoeys J, Tjwa M, Van Linthout S, De Geest B. Human apo A-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28(2):278-83
Aragonés J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M, Dirkx R, Zacchigna S, Lemieux H, Jeoung N, Lambrechts D, Bishop T, Lafuste P, Diez-Juan A, Harten S, Van Noten P, De Bock K, Willam C, Tjwa M, Grosfeld A, Navet R, Moons L, Deroose C, Wijeyekoon B, Nuyts J, Jordan B, Silasi-Mansat R, Lupu F, Dewerchin M, Pugh C, Salmon P, Mortelmans L, Gallez B, Gorus F, Buyse J, Sluse F, Harris B, Gnaiger E, Hespel P, Van Hecke P, Schuit F, Van Veldhoven P, Ratcliffe P, Baes M, Maxwell P, Carmeliet P. Deficiency or inhibition of the oxygen sensor PHD1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 2008;40(2):170-80 ("recommended (3.0)" in Faculty of 1000)
2007
Tirziu D, Chorianopoulos E, Moodie K, Palac R, Zhuang Z, Tjwa M, Roncal C, Eriksson U, Fu Q, Elfenbein A, Hall A, Carmeliet P, Moons L, Simons M. Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. J Clin Invest 2007;117(11):3188-97 (with editorial)
Jost M, Maillard C, Lecompte J, Lambert V, Tjwa M, Blaise P, Alvarez Gonzalez M, Bajou K, Blacher S, Motte P, Humblet C, Defresne M, Thiry M, Frankenne F, Gothot A, Carmeliet P, Rakic J, Foidart J, Noël A. Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I (PAI-1). Am J Pathol 2007;171(4):1369-80
Moura R, Tjwa M, Vandervoort P, Cludts K, Hoylaerts M. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation. Arterioscler Thromb Vasc Biol 2007;27(10):2163-9
Suelves M, Vidal B, Serrano A, Tjwa M, Roma J, López-Alemany R, Luttun A, Martínez de Lagrán M, Angels Diaz M, Jardí M, Roig M, Dierssen M, Dewerchin M, Carmeliet P, Muñoz-Cánoves P. uPA deficiency exacerbates muscular dystrophy in mdx mice. J Cell Biol 2007;178:1039-51
Umans L*, Cox L*, Tjwa M, Bito V, Vermeire L, Laperre K, Sipido K, Moons L, Huylebroeck D, Zwijsen A (*contributed equally). Inactivation of Smad5 in endothelial cells and smooth muscle cells demonstrates that Smad5 is required for cardiac homeostasis. Am J Pathol 2007;170:1460-72
2006
Lijnen HR, Christiaens V, Scroyen I, Voros G, Tjwa M, Carmeliet P, Collen D. Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes 2006;55:2698-2704
Vangheluwe P, Tjwa M, Van den Bergh A, Louch W, Beullens M, Dode L, Carmeliet P, Kranias E, Herijgers P, Sipido K, Raeymaekers L, Wuytack F. A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span. J Mol Cell Cardiol 2006;41(2):308-17
Tjwa M, Carmeliet P, Moons L. A novel transgenic rabbit model sheds light on the puzzling role of MMP-12 in atherosclerosis. Circulation 2006;113:1929-32
2005
Schneider M, Tjwa M, Carmeliet P. A surrogate marker to monitor angiogenesis at last. Cancer Cell 2005;7(1):3-4
Acker T*, Diez-Juan A*, Aragones J*, Tjwa M, Brusselmans K, Moons L, Fukumura D, Moreno-Murciano M, Herbert J, Burger A, Riedel J, Elvert G, Flamme I, Maxwell P, Collen D, Dewerchin M, Jain R, Plate K, Carmeliet P (*contributed equally). Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell 2005;8(2):131-41 ("must read (6.0)" in Faculty of 1000)
Li X*, Tjwa M*, Fons P, Moons L, Noel A, Ny A, Zhou J, Lennartson J, Li H, Luttun A, Pontén A, Devy L, Bouché A, Oh H, Manderveld A, Blacher S, Savi P, Dewerchin M, Bono F, Foidart J, Autiero M, Herbert JM, Heldin C, Eriksson U, Carmeliet P (*contributed equally). Revascularization of ischemic tissues by PDGF-CC: effects on endothelial (progenitor) cells. J Clin Invest 2005;115:118-27 (with comment in N Eng J Med, and "must read (6.0)" in Faculty of 1000))
2004
Luttun A, Autiero M, Tjwa M, Carmeliet P. Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets? Biochim Biophys Acta 2004;1654(1):79-94
Luttun A*, Tjwa M* and Carmeliet P (*contributed equally). The formation of blood and lymphatic vessels: role of progenitors. In: Handbook of Stem Cells 2004;2:455-74. Edited by Weissman I, Melton D, Verfaillie C, Moore M, Blau H, West M and Lanza R.
Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard M, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch K. Cardiomyocyte-specific overexpression of Nitric Oxide Synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial Infarction. Circ Res 2004;94:1256-62
Molinas C, Tjwa M, Vanacker B, Binda M, Elkelani O, Koninckx P. Role of CO2 pneumoperitoneum-induced acidosis in CO2 pneumoperitoneum-enhanced adhesion formation in mice. Fertil Steril 2004;81(3):708-11
2003
Brusselmans K, Compernolle V, Tjwa M, Wiesener M, Maxwell P, D Collen, Carmeliet P. Heterozygous deficiency of the hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest 2003;111:1519-27
Tjwa M, Luttun A, Autiero M, Carmeliet P. VEGF and PlGF: two pleitropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res 2003;314(1):5-14
Autiero M, Luttun A, Tjwa M, Carmeliet P. PlGF and its receptor VEGFR-1 (Flt1): novel targets to stimulate ischemic tissue revascularization and inhibit angiogenic and inflammatory disorders. J Thromb Haemost 2003;1:1356-70 (awarded with J Thromb Haemost Picture Prize 2003).
2002
Luttun A, Tjwa M, Carmeliet P. Placental Growth Factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann NY Acad Sci USA 2002;979:80-93
Luttun A, Brusselmans K, Fukao H, Tjwa M, Ueshima S, Herbert J, Matsuo O, Collen D, Carmeliet P, Moons L. Loss of Placental Growth Factor (PlGF) protects mice against vascular permeability in pathological conditions. Biochem Biophys Res Commun 2002;295:428-34
Luttun A*, Tjwa M*, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy J, Hooper A, Priller J, De Klerck B, Compernolle V, Bohlen P, Dewerchin M, Herbert J, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak H, Hicklin D, Carmeliet P (*contributed equally). Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt-1 antibody. Nature Medicine 2002;8(8):831-40 (cover with News & Views; editorials in Nature Cancer Reviews, Nature)
Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nature Medicine 2002;8(7):702-10 (with News & Views)
2001
Tjwa M, De Hertogh G, Neuville B, Roskams T, Nevens F, Van Steenbergen W. Hepatic fibrin-ring granulomas in granulomatous hepatitis: report of four cases and review of the literature. Acta Clinica Belgica 2001;56(6):341-8
Tjwa M, Verhoef G. Thrombotic Thrombocytopenic Purpura: Case Report and review of the literature. Tijdschrift voor Geneeskunde 2001; 57(9): 674-81.